Electrophysiological investigation of the contribution of attention to altered pain inhibition processes in patients with irritable bowel syndrome by Rustamov, Nabi et al.




of the contribution of attention to altered pain 
inhibition processes in patients with irritable 
bowel syndrome
Nabi Rustamov1,2, Alice Wagenaar‑Tison1,2, Elysa Doyer1,2 and Mathieu Piché1,2* 
Abstract 
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder associated with chronic abdominal pain and 
altered pain processing. The aim of this study was to examine whether attentional processes contribute to altered 
pain inhibition processes in patients with IBS. Nine female patients with IBS and nine age‑/sex‑matched controls 
were included in a pain inhibition paradigm using counter‑stimulation and distraction with electroencephalogra‑
phy. Patients with IBS showed no inhibition of pain‑related brain activity by heterotopic noxious counter‑stimulation 
(HNCS) or selective attention. In the control group, HNCS and selective attention decreased the N100, P260 and high‑
gamma oscillation power. In addition, pain‑related high‑gamma power in sensorimotor, anterior cingulate and left 
dorsolateral prefrontal cortex was decreased by HNCS and selective attention in the control group, but not in patients 
with IBS. These results indicate that the central pain inhibition deficit in IBS reflects interactions between several brain 
processes related to pain and attention.
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Background
Irritable bowel syndrome (IBS) is a functional gastroin-
testinal (GI) disorder characterized by chronic abdominal 
pain and bowel dysfunction [1]. IBS may be associated 
with psychological distress, impaired quality of life, and 
disability, and it constitutes a serious societal and eco-
nomic burden due to its high prevalence [2]. Although 
several mechanisms have been proposed, the underlying 
physiopathology of chronic pain in IBS remains unclear.
A consistent finding reported in several studies in 
patients with IBS is the alteration of central pain inhibi-
tion mechanisms [3–10]. Considering that altered pain 
inhibition is associated with widespread hyperalgesia, it 
is possible that mechanisms related to diffuse noxious 
inhibitory controls (DNIC) or conditioned pain modu-
lation (CPM) may be disrupted in IBS. Indeed, DNIC 
produce diffuse analgesia [11–16] and their dysfunction 
may cause diffuse pain hypersensitivity. Other factors 
that may contribute to chronic pain in IBS include altered 
cognitive functions and attentional processes, which may 
also lead to widespread pain hypersensitivity indepen-
dently of the original source of pain.
Regarding cognitive functions, cognitive perfor-
mance is lower in patients with chronic pain [17] and 
decreased cognitive inhibition may be associated with 
reduced pain inhibition [18], although this remains to be 
demonstrated in patients with chronic pain. In patients 
with IBS, reduced cognitive performance may affect 
how pain symptoms are processed and perceived and 
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may contribute to altered pain inhibition, exacerbating 
chronic pain symptoms. A deficit in episodic visuospatial 
memory suggests that cognitive functions are altered in 
patients with IBS [19], although this remains to be repli-
cated [20].
Regarding attention to pain, pain hypervigilance 
increases pain perception [21, 22]. Also, enhanced atten-
tional capture by pain due to attentional bias towards 
pain-related information was reported in patients with 
chronic pain [23, 24]. More specifically, patients with 
IBS show attentional biases for situational threat words, 
which is reflected in Stroop facilitation and is associ-
ated with gastrointestinal function anxiety [25]. Moreo-
ver, they show lower attentional control in an attention 
network task [26], which could increase attentional cap-
ture by pain. Considering that attention to pain generally 
increases pain perception and that pain inhibition mech-
anisms such as DNIC/CPM may be modulated by atten-
tion [27, 28], enhanced attentional capture by pain could 
contribute to chronic pain symptoms in IBS.
The aim of this study was to examine whether the 
modulation of pain-related brain activity by selective 
attention may be impaired and thus contribute to altered 
inhibition by heterotopic noxious counter-stimulation 
(HNCS) in patients with IBS. We also examined whether 
pain vigilance is increased and whether cognitive inhi-
bition is decreased in patients IBS. We hypothesized 
that patients with IBS would show decreased inhibition 
of pain-related brain activity by selective attention and 
HNCS. Furthermore, we hypothesized that pain hyper-
vigilance and decreased cognitive inhibition would con-
tribute to these alterations in patients with IBS.
Methods
Ethics approval
All experimental procedures conformed to the standards 
set by the latest revision of the Declaration of Helsinki 
and were approved by the Research Ethics Board of the 
Université du Québec à Trois-Rivières. All participants 
gave a written informed consent acknowledging their 
right to withdraw from the experiment without prejudice 
and received compensation for their time and commit-
ment to the study. The study consisted of 3 sessions of 
90  min each, including the determination of thresholds 
(pain and the nociceptive flexion reflex NFR) and the 
evaluation of pain perception, NFR, and somatosensory 
evoked potentials (SEP).
Study participants
Patients with IBS: Nine patients with diarrhea-predomi-
nant IBS (9 women; mean age ± standard deviation [SD]: 
28.9 ± 10.3 years) were recruited for the study by referrals 
from the gastroenterology unit of the Centre hospitalier 
affilié universitaire régional de Trois-Rivières (QC, Can-
ada). All patients were evaluated by gastroenterologists 
experienced in the evaluation of IBS. To make the diag-
nosis of IBS, normal physical examination, normal colo-
noscopy with biopsy, exclusion of organic diseases, and 
the presence of IBS symptoms based on Rome III criteria 
were required. Patients were excluded if they presented 
with other chronic pain syndromes, diagnosed psychi-
atric disorders, or used any medication that could alter 
pain perception (e.g., analgesics, anxiolytics, antidepres-
sants, and other psychotropic agents) 2  weeks prior to 
the experiment.
Control group: Nine age- and gender-matched healthy 
controls (9 women; mean age ± standard deviation [SD]: 
28.5 ± 8.5  years) volunteered to participate in the study. 
They were recruited by advertisements at the campus of 
the Université du Québec à Trois-Rivières. Participants 
were included if they had normal bowel habits and no 
known gastrointestinal disease and were excluded for: 
(1) taking any medication altering pain perception within 
2  weeks prior to the experiment, and (2) having a his-
tory of gastrointestinal symptoms, chronic pain, acute or 
chronic illness, or a diagnosed psychiatric disorder.
Psychometric assessment
All participants completed the following validated ques-
tionnaires before the experiment: the MOS 36-Item 
Short-Form Health Survey for psychological distress and 
physical health [29], the Pain Catastrophizing Scale [30], 
the Pain Vigilance and Awareness questionnaire [31], the 
Beck Depression Inventory-II [32], and the French ver-
sion of the State–Trait Anxiety Inventory [33]. In addi-
tion, the St-Luc Gastrointestinal Index (GI) was used to 
assess severity of GI symptoms in patients with IBS [34, 
35].
Assessment of cognitive inhibition
Prior to the experiment, subjects performed a computer-
ized modified Stroop task involving four different con-
ditions (reading, naming, inhibition, and switching), as 
used previously [36]. In the reading condition, partici-
pants read words denoting colors that were displayed in 
fonts of the same color (red, blue, yellow, or green). In the 
color-naming condition, participants named the colors of 
noncolor words that were displayed in one of the same 
four font colors (neutral condition). In the inhibition con-
dition, participants named the color of the font of incon-
gruent color words (incongruent condition, e.g., the word 
RED displayed in green font). In the switching condi-
tion, participants named the color of the font in which an 
incongruent color word was displayed when the word is 
preceded by a cross (similar to the inhibition condition) 
but read the word when it was preceded by a rectangle. 
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Participants were instructed to perform the tasks as fast 
and as accurately as possible. In the switching condition, 
a maximum of 3 naming or reading trials were presented 
consecutively and performance was decomposed to dis-
tinguish the initial switching trial reflecting the change 
in task-set from the consecutive trials. The analysis of 
the Stroop interference focused on the consecutive trials 
following the first switching trial. Performance in these 
consecutive trials reflected the inhibition process within 
the context of switching, without including the switch-
ing effect. The reaction times (RT) were extracted and 
the mean value of the 60 trials for each condition was 
calculated after removing the first four trials to exclude 
adaptation effects. To calculate the interference effect 
in the switching condition, the mean RT of the naming 
condition, serving as a control, was subtracted from the 
mean RT of the inhibition trials of the switching condi-
tion. This calculated interference effect reflects the cost 
of cognitive inhibition (Stroop interference) in the con-
text of task-switching.
Experimental design
This study relied on a between-group design to exam-
ine the effects of selective attention and HNCS on 
acute shock pain, the associated electrophysiologi-
cal responses including SEP, cerebral oscillations and 
their sources, and the NFR. Each participant completed 
three 90-min sessions (control session, attention to 
shock pain session, and attention to counter-stimula-
tion session) separated by a 1–2-week interval (Fig. 1). 
For the experiment, they sat comfortably on a chair 
with knee flexion of approximately 120°. In each ses-
sion, after the NFR threshold assessment, 15 electri-
cal shocks were applied to confirm the NFR stability. 
For the experimental conditions, 80 painful electrical 
stimuli were delivered at varying intervals of 6–15  s, 
distributed in four blocks of 20 stimuli each. In the con-
trol session, participants were instructed to pay atten-
tion to the electrical shocks. Electrical shocks were 
applied with no counter-stimulation and participants 
were prompted to rate shock pain every 5 stimuli and 
after each block of 20 shocks. In the attention to shock 
pain and the attention to counter-stimulation sessions, 
heterotopic innocuous counter-stimulation (HICS) and 
HNCS were applied during the second and third blocks, 
respectively. This allowed evaluation of the modulation 
of brain activity, pain perception, and NFR induced by 
HNCS and selective attention. Top–down focusing of 
attention was manipulated across these two sessions. In 
the attention to shock pain session, participants were 
instructed to focus their attention on shocks. They were 
prompted to rate shock pain every 5 stimuli. In addi-
tion, they rated the non-painful coolness of HICS and 
pain induced by HNCS at the end of the respective 
blocks. In the attention to counter-stimulation session, 
participants were instructed to focus their attention on 
the counter-stimulation applied on their left forearm 
(HICS or HNCS). They were prompted to rate the non-
painful coolness of HICS and pain induced by HNCS 
every 5 stimuli. Additionally, they rated shock pain at 
the end of each block. Session order was counterbal-
anced across subjects.
Painful electrical stimulation (test stimulus)
Transcutaneous electrical stimulation (trains of 
10 × 1 ms pulses at 333 Hz) was delivered with an iso-
lated DS7A constant current stimulator (Digitimer Ltd., 
Welwyn Garden City, Hertfordshire, UK) triggered by a 
Grass S88 train generator (Grass Medical Instruments, 
Quincy, MA, USA) and controlled by a computer with 
a stimulus presentation program (E-Prime2, Psychology 
Software Tools, Sharpsburg, PA, USA). Degreased skin 
over the retromalleolar path of the right sural nerve was 
stimulated by a pair of custom-made surface electrodes 
(1 cm2; 2 cm inter-electrode distance). The NFR thresh-
old was determined using the staircase method including 
four series of stimuli of increasing and decreasing inten-
sity [8, 37, 38]. Each series always began with a stimu-
lus intensity of 1  mA, followed by stimuli increasing in 
intensity in increments of 1 mA, reaching a suprathresh-
old level between 10 and 25 mA (clearly above threshold, 
but adjusted individually to avoid severe pain). Stimulus 
intensity was then decreased by steps of 1 mA. After four 
of these series were completed, the NFR amplitude was 
plotted against the stimulus intensity (recruitment curve) 
and threshold was defined as the intensity producing a 
clear response in at least 50% of trials (responses clearly 
above background electromyogram [EMG], as defined by 
the maximum artefact-free EMG activity observed in the 
same post-stimulus interval [90–180 ms] across all sub-
threshold stimuli). The pain threshold was defined as the 
lowest stimulus intensity evoking pain. The intensity of 
stimulation was then adjusted individually at 120% of the 
NFR threshold and remained constant during the rest of 
the experiment.
Heterotopic noxious counter‑stimulation (HNCS: 
conditioning stimulus)
HNCS was produced by the application of a cold pack 
on the left forearm (contralateral to the acute shock pain 
stimulus) for 3 min. This flexible bag (15 × 20 cm), filled 
with 500 mL of gel, covered most of the anterior forearm 
surface. When applied, the cold pack was approximately 
− 12 °C and produced moderate pain.
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Heterotopic innocuous counter‑stimulation (HICS: 
conditioning stimulus)
HICS was delivered with a 9  cm2 contact thermode 
(model TSA-2001; Medoc Advanced Medical Systems, 
Ramat Yishai, Israel) applied on the anterior surface of 
the left forearm. Stimulation was continuous for 3 min 
with slight temperature changes every 10  s (16–17–
18–19  °C in pseudo-random order) to reduce the risk 
of sensory adaptation without introducing major shifts 
in sensory input. As innocuous stimuli do not typically 
trigger noxious inhibitory controls [12], HICS was used 
to control for potential non-specific effects of coun-
ter-stimulation. Moreover, HICS was used to direct 
attention away from the shock pain stimuli by asking 
subjects to rate the sensation of HICS coolness. Stimu-
lus rating as a distraction task was applied, because it 
involves cognitive–evaluative processes that are more 
comparable to those presumably involved in the HNCS 
paradigm. In typical HNCS paradigms, conditioning 
stimuli are applied heterotopically, thus activating pro-
cesses related to spatial attention towards a competing 
sensory signal.
Fig. 1 Experimental paradigm. Participants underwent three counterbalanced sessions, including the control session (top panel), attention 
to shock pain session (middle panel), and attention to counter‑stimulation session (bottom panel). Each session included four blocks of 20 
painful electrical stimuli delivered at varying intervals of 6–15 s over the right sural nerve. In the attention to shock pain and the attention to 
counter‑stimulation sessions, heterotopic innocuous and noxious counter‑stimulation (HICS and HNCS, blue and red blocks, respectively) were 
applied during the second and third blocks. In the attention to shock pain session, participants were instructed to focus their attention on the 
shocks and to rate shock pain at regular intervals (black arrows). In addition, they were instructed to rate the coolness of HICS and the pain induced 
by HNCS at the end of the respective blocks (blue and red arrows, respectively). In the attention to counter‑stimulation session, participants were 
instructed to focus their attention on the counter‑stimulation applied on their left forearm (HICS or HNCS). They were instructed to rate HICS or 
HNCS at regular intervals (blue and red arrows) and shock pain at the end of each block (black arrows)
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Pain ratings
A visual analogue scale (VAS) was shown to participants 
on a computer monitor to prompt the evaluation of 
pain produced by electrical stimulation and HNCS. The 
VAS was arranged horizontally and included the verbal 
anchors “no pain” and “worst pain imaginable” at the left 
and right extremities, respectively [39]. HICS was rated 
on a scale that included the verbal anchors “no sensation” 
and “cold pain threshold” at the left and right extremities, 
respectively. Participants were instructed to rate their 
pain or cold sensation according to these scales, when 
prompted, by verbally providing numbers between 0 and 
100, which corresponded to the left and right anchors of 
the scales.
Electroencephalographic recording
Continuous electroencephalogram (EEG) was recorded 
by means of a 64-channel BrainAmp amplifier, using 
active Ag–AgCl electrodes that were mounted on an 
actiCAP in an International 10–20 System montage 
(Brain Products, Gilching, Germany). Electrode imped-
ance was kept below 10  kΩ. Electrooculographic activ-
ity was recorded using a pair of electrodes placed at the 
suborbital ridge (vertical electrooculogram, vEOG) and 
at the external ocular canthus (horizontal electrooculo-
gram, hEOG) of the right eye. All EEG electrodes were 
referenced to the nose with a ground electrode placed on 
the forehead. EEG and EOG signals were filtered with a 
0.01–100 Hz band pass and sampled at 500 Hz for offline 
analyses.
Somatosensory evoked potentials
EEG data was analyzed in MATLAB (Mathworks, Nat-
tick, MA, USA) using EEGLAB version 14_1_1b [40]. 
Data was filtered offline using a FIR band pass filter with 
the lower edge at 0.1  Hz and the higher edge at 30  Hz. 
SEPs were time-locked to the right sural nerve stimu-
lation and baseline-corrected between − 100  ms and 
0 prior to the right sural nerve stimulation. Data was 
screened for extreme values, as well as for infrequent 
and unstereotyped artifacts using the inbuilt probabil-
ity function (pop_jointprob) with a threshold of 3 SD56. 
For further artifact attenuation, Infomax independent 
component analysis (ICA) was applied. Artifacts were 
identified using the EEGLAB-Runica function, and inde-
pendent components (IC) found to reflect blinks, lateral 
eye movements, muscle-related, and cardiac artifacts 
were removed from the data. Following ICA-based arti-
fact attenuation, SEPs were averaged for each condition. 
The amplitude of the P45, N100, and P260 components 
was quantified using the mean amplitude between fixed 
latencies (P45: 45–55 ms post-stimulus; N100: 90–120 ms 
post-stimulus; P260: 280–350 ms post-stimulus).
Time–frequency analysis
Time–frequency analysis was performed in the MAT-
LAB environment using EEGLAB version 14_1_1b [40] 
to examine event-related spectral perturbations (ERSPs). 
The analysis allows examining brain oscillations that are 
produced by painful stimuli and how they are modu-
lated by the experimental conditions. It provides fur-
ther investigation of pain perception and pain regulation 
mechanisms.
EEG was filtered offline using a FIR band pass fil-
ter (1–100  Hz). As described above for ERPs, data was 
screened for extreme values as well as for infrequent and 
unstereotyped artifacts, and ICA analysis was applied 
to remove remaining artifacts. Data was segmented into 
stimulus-locked epochs from − 1600 to 2600  ms, with 
time 0 corresponding to the onset of electrical shocks. A 
Morlet wavelet convolution [41] was computed using the 
channel time–frequency options available on EEGLAB 
14_1_1b [40]. Two hundred time points were gener-
ated and 100 linearly spaced frequencies were computed 
from 1 to 100 Hz. Variable cycles were used for low and 
high frequencies, with 3 cycles for lowest frequencies 
and up to 15 cycles for highest frequencies. This allowed 
the wavelet convolution method to provide a better fre-
quency resolution at lower frequencies and a better tem-
poral resolution at higher frequencies [42]. ERSPs were 
computed in decibels relative to the − 400 to − 100  ms 
baseline for each time and frequency point [43, 44].
To examine specific ERSPs, a hypothesis-driven 
approach was used based on previous studies [67]. Mean 
power values in four time–frequency maps from the 
Cz electrode signal were extracted in predetermined 
regions of interest (time × frequency) from 4 to 10  Hz 
between 50 and 350  ms, from 8 to 29  Hz between 300 
and 1000 ms, from 30 to 60 Hz between 50 and 300 ms, 
and from 61 to 100  Hz between 100 and 300  ms. The 
gamma band was separated into low and high frequency 
components [45]. The ERSP value for each time–fre-
quency point (ERSPtf ) included in the regions of interest 
was calculated for each subject. A mean ERSPtf value was 
then obtained for each subject over the regions of inter-
est by averaging the values for the 20% highest power (for 
power increase relative to the baseline) or 20% lowest 
power (for power decreases relative to the baseline). This 
procedure has been used in previous studies for time–
frequency analysis [46–49] and has the main advantage 
of allowing the selection of wide regions of interests, 
thus taking into account variability across subjects while 
reducing the regression to the mean problem with near-
zero values. For each participant, time–frequency data 
was averaged across all trials per block. The grand aver-
age time–frequency maps for the group were obtained by 
averaging data across subjects for each block.
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Source estimation analysis
A source estimation package implemented in Brain-
storm software was used to estimate the cortical sources 
of high-gamma oscillations [50]. The forward model 
was calculated using the Open-MEEG Boundary Ele-
ment Method [51] on the cortical surface of a template 
(MNI brain-colin27 atlas) with 1 mm resolution. A noise 
covariance matrix was estimated from the preproc-
essed EEG data. Cortical source activation was calcu-
lated with a constrained inverse model of EEG sources 
using the weighted minimum norm current estimation 
[52] and mapped to a distributed source model consist-
ing of 15,002 elementary current dipoles. We then com-
puted time–frequency decomposition on the source time 
series for each trial using the Morlet transform from 60 
to 100 Hz in 1 Hz steps. The resulting maps across trials 
were averaged for each subject. Consistent with the time–
frequency analysis on the electrodes, the source analysis 
focused on the time window of the high-gamma oscil-
lations (100–300 ms). Two-tailed t tests between condi-
tions (attention to shock pain session, HNCS vs. baseline; 
attention to counter-stimulation session, HICS vs. base-
line) were applied to each point in space to identify sta-
tistically significant voxels (frequency range 70–90  Hz, 
time window 0–300 ms). To minimize the possibility of 
erroneous results, we presented source estimations if the 
statistically significant differences at the source level sur-
vived the 5% FDR-based multiple comparison correction.
NFR measurement and analysis
Electromyography (EMG) of the short head of the right 
biceps femoris was recorded with a pair of surface elec-
trodes (EL-508, Biopac Systems, Inc., Goleta, CA, 
USA). It was amplified 1000 times, band pass filtered 
(10–500 Hz), sampled at 1000 Hz (Biopac Systems), and 
stored on a personal computer for offline analysis using 
Acknowledge 4.1.1 software. The raw EMG recording 
was full-wave rectified and the resulting signal was used 
to quantify the amplitude of the NFR to each shock by 
extracting the integral value between 90 and 180 ms after 
the stimulus onset [8, 18, 27, 28, 37, 53, 54]. This ampli-
tude was normalized for each electrical stimulus using a 
t-transformation. The mean of 20 responses in each block 
was calculated to compare blocks within and between 
sessions.
Statistical analyses
All results are expressed as mean ± SD unless speci-
fied. The data was analyzed with Statistica v13.1 (Dell 
Inc. 2016, Tulsa, OK, USA) with significance thresholds 
set to p ≤ 0.05. Group differences in psychological vari-
ables were assessed by t tests for independent samples. 
The modulation of SEPs, ERSPs, pain ratings, and NFR 
between groups across sessions and blocks was assessed 
by mixed analysis of variance (ANOVA) with Group 
(patients with IBS, control group) as the between subject 
factor and Session (control, attention to shock pain, and 
attention to counter-stimulation) and Block (baseline, 
HICS, HNCS, and recovery) as within-subject factors. 
Planned contrasts were used to decompose significant 
effects and to test a priori hypotheses for inhibitory 
effects of HNCS and selective attention. Effect sizes are 
reported based on partial eta-squared ( η2p).
Results
Groups characteristics
Characteristics of patients with IBS and the control group 
are reported in Table 1. The mean duration of IBS symp-
toms was 11.0 ± 2.5 years and the severity of gastrointes-
tinal symptoms was moderate (St-Luc scale: 69.4 ± 19.3). 
Patients with IBS showed significantly lower mental 
health (45 ± 8.8 vs. 56.1 ± 6.7, p < 0.008) and physical 
health (43 ± 5.5 vs. 52.3 ± 4.8, p < 0.001) compared with 
the control group. Moreover, patients with IBS reported 
higher pain vigilance (Pain Awareness and Vigilance 
Questionnaire: 43.3 ± 8.8 vs. 27.8 ± 14.3, p < 0.01) and 
pain catastrophizing (Pain Catastrophizing Question-
naire: 24.1 ± 12 vs. 10.9 ± 8.5, p < 0.02) compared with the 
control group. The NFR threshold was significantly lower 
in patients with IBS compared with the control group 
(10.7 ± 4.8 vs. 15.4 ± 3.5, p < 0.02), but baseline shock pain 
ratings were not significantly different between groups 
(46.3 ± 15.9 vs. 41.6 ± 17.2, p = 0.3). In the Stroop test, 
reaction times (RT) in the inhibition trials of the switch-
ing condition were higher in patients with IBS compared 
with the control group although this effect did not reach 
statistical significance (982 ± 170  ms vs. 842 ± 109  ms, 
p = 0.054), while RT were not significantly different in the 
naming condition (754 ± 36 ms vs. 663 ± 36 ms, p = 0.10).
Altered inhibition of pain‑related brain activity 
by heterotopic noxious counter‑stimulation (HNCS) 
and selective attention in patients with IBS
The grand averages of SEPs and scalp topography of the 
N100 and P260 components are presented in Fig. 2. The 
comparison of mean amplitudes between groups across 
sessions and blocks for the P45, N100, and P260 meas-
ured at Cz is reported in Table  2 and Fig.  3. Statistical 
within-session comparisons are also presented in Table 2 
and Fig. 3.
P45 mean amplitude
The P45 mean amplitude was not significantly different 
between groups across sessions and blocks (interaction: 
 F6,96 = 0.4, p = 0.9, η2p = 0.02). Also, it was not significantly 
different between sessions across blocks (interaction: 
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 F6,96 = 0.3, p = 0.9, η2p = 0.02). These results indicate that 
HNCS and selective attention did not modulate the P45 
significantly.
N100 and P260 mean amplitude
The N100 and P260 mean amplitudes were signifi-
cantly different between groups across sessions and 
blocks (interaction:  F6,96 = 4.8, p < 0.001, η2p = 0.23 and 
 F6,96 = 5.7, p < 0.001, η2p = 0.26, respectively). These 
interactions were then decomposed using planned con-
trasts to test a priori hypotheses.
In the control session, the mean amplitudes of the 
N100 and P260 were not significantly different in the 
second, third, or fourth blocks compared with the 
baseline block for either patients with IBS (all p > 0.4) 
or controls (all p > 0.5). This indicates that non-specific 
Fig. 2 Modulation of somatosensory evoked brain potentials by selective attention and heterotopic noxious counter‑stimulation (HNCS). Grand 
average somatosensory evoked potentials (SEP) recorded at Cz and scalp topography of components showing significant modulation by selective 
attention and HNCS (N100 and P260) are presented for each block, session, and group (patients with IBS, left column; control group, right column). 
The three components that were analyzed (P45, N100, and P260) are indicated on the bottom left panel. For mean amplitudes of the components 
and statistical results, see Table 2, Fig. 3, and the results section. X‑axis, time in ms; Y‑axis, amplitude in μV. IBS: irritable bowel syndrome; HICS: 
heterotopic innocuous counter‑stimulation; HNCS: heterotopic noxious counter‑stimulation
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temporal changes in N100 and P260 were not 
significant.
In the attention to shock pain session, HICS did not 
significantly modulate the N100 and P260 in compari-
son to baseline in either patients with IBS (both p > 0.5) 
or controls (both p > 0.3), indicating a lack of N100 and 
P260 modulation by heterotopic non-painful cold stimu-
lation. In contrast, HNCS decreased the N100 and P260 
compared with HICS and these effects were significant 
compared with the corresponding changes in the con-
trol session, for controls compared with patients with 
IBS (both p < 0.01). Indeed, N100 and P260 inhibition 
by HNCS was significant in controls (both p < 0.001) but 
not in patients with IBS (both p > 0.6). This indicates that 
HNCS inhibited the N100 and P260 after accounting for 
non-specific temporal changes in controls, but not in 
patients with IBS. In controls, the N100 remained sig-
nificantly decreased during recovery compared with the 
HICS block, vs. the corresponding changes in the control 
session (p < 0.001), but this was not the case for the P260 
(p = 0.4).
In the attention to counter-stimulation session, the 
mean amplitude of the N100 and P260 was significantly 
decreased by HICS compared with baseline vs. the corre-
sponding changes when attention was focused on shock 
pain, and these effects of selective attention were signifi-
cantly different between groups (both p < 0.03). Indeed, 
selective attention inhibited the N100 and P260 in con-
trols the control group (both p < 0.02) but not in patients 
with IBS (both p > 0.4). This indicates that selective atten-
tion inhibited the N100 and P260 after accounting for 
temporal non-specific changes in the control group, but 
not in patients with IBS. Moreover, HNCS produced sig-
nificant N100 and P260 inhibition compared with HICS, 
vs. the corresponding changes in the attention to shock 
pain session, and these effects were significantly different 
between groups (both p < 0.04). Indeed, these effects were 
significant in the control group (both p < 0.02) but not in 
Fig. 3 Modulation of somatosensory evoked brain activity by selective attention and heterotopic noxious counter‑stimulation (HNCS). Amplitude 
(mean ± SEM) of the N100 and P260 components (a, b, respectively) for each block, session, and group (patients with IBS, left column; control 
group, right column). For mean amplitudes of the components and statistical results, see Table 2 and “Results” section. The inhibitory effect of HICS 
and HNCS compared with baseline within each session is represented by the *, †, and ‡ symbols. *p < 0.05, †p < 0.01, ‡p < 0.001. The inhibitory effect 
of HNCS compared with HICS vs. the corresponding changes in the control session is represented by the # symbol. The inhibitory effect of HICS 
compared with baseline and HNCS compared with HICS vs. the corresponding changes in the attention to shock pain session are represented by 
the & symbol. #p < 0.001; &p < 0.05. X‑axis, conditions and sessions; Y‑axis, amplitude in μV. NRS: numerical rating scale; SEM: standard error of the 
mean; IBS: irritable bowel syndrome; HICS: heterotopic innocuous counter‑stimulation; HNCS: heterotopic noxious counter‑stimulation
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patients with IBS (both p > 0.4), suggesting that HNCS 
and selective attention produced additive inhibition of 
brain activity related to the N100 and P260 in the control 
group only. This also suggests that the lack of inhibition 
by selective attention may contribute to altered inhibi-
tion by HNCS in IBS, which is supported by a significant 
correlation between inhibition of the N100 by HNCS and 
selective attention (r = 0.47; p = 0.050) and inhibition 
of the P260 by HNCS and selective attention (r = 0.50; 
p = 0.035).
Event‑related spectral perturbations
To examine cerebral processes underlying the reduction 
in brain activity induced by HNCS and selective atten-
tion, the modulation of pain-related brain oscillations 
was investigated using ERSP analyses. ERSP analysis was 
based on regions of interests in the time–frequency map 
of Cz (see Fig. 4 and Table 2).
The mean power of high-gamma oscillations was sig-
nificantly different between groups across sessions and 
blocks (interaction:  F6,96 = 2.2, p = 0.047, η2p = 0.12; see 
Table  2 and Fig.  4). No effect was observed between 
groups across sessions and blocks for regions of interest 
in other frequency bands (see Table 2). Statistical within-
session comparisons are also presented in Table  2 and 
Fig. 4.
Planned contrasts revealed that in the control session, 
the mean power of high-gamma oscillations was not sig-
nificantly different in the second, third, and fourth blocks 
compared with the baseline block for either patients with 
IBS (all p > 0.3) or the control group (all p > 0.3). This 
excludes temporal non-specific changes in the mean 
power of high-gamma oscillations.
In the attention to shock pain session, HICS did not sig-
nificantly modulate high-gamma oscillations in compari-
son to baseline either in patients with IBS (both p > 0.3) 
or the control group (both p > 0.2), indicating a lack of 
high-gamma modulation by heterotopic non-painful 
cold stimulation. In contrast, HNCS decreased the mean 
power of high-gamma oscillations compared with HICS, 
vs. the corresponding changes in the control session, and 
this effect of HNCS was significantly different between 
groups (p < 0.04). Indeed, HNCS inhibited high-gamma 
oscillations in the control group (p < 0.04) but not in 
patients with IBS (p = 0.4). After HNCS, the mean power 
of high-gamma oscillations did not remain significantly 
decreased compared with the HICS block vs. the corre-
sponding changes in the control session (p = 0.6). This 
indicates that pain-related brain processes underlying 
cerebral oscillations in the high-gamma range are inhib-
ited during the heterotopic application of another painful 
stimulus in healthy individuals, but not in patients with 
IBS.
In the attention to counter-stimulation session, the 
mean power of high-gamma oscillations was not signifi-
cantly modulated by HICS compared with baseline, vs. 
the corresponding changes in the attention to shock pain 
session for the control group compared with patients 
with IBS (p = 0.13). Indeed, no effect of selective atten-
tion was observed for either patients with IBS (p > 0.2) 
or the control group (p > 0.2). In addition, high-gamma 
oscillations were not significantly modulated by HNCS 
compared with HICS, vs. the corresponding contrast in 
the attention to shock pain session for the control group 
compared with patients with IBS (p > 0.3). Indeed, this 
effect was not significant either in patients with IBS 
(p > 0.7) or the control group (p > 0.3), indicating that 
HNCS and selective attention did not produce significant 
additive inhibition of high-gamma oscillations, consistent 
with the lack of effect of selective attention.
Source estimation of high‑gamma oscillation modulation
To examine the sources of high-gamma power decrease 
by HNCS and selective attention compared with base-
line, source estimation was calculated. At baseline, pain-
related activity induced by the shock-evoked robust 
gamma oscillations in several pain-related areas in both 
groups (bilateral foot region of primary somatosensory 
cortex [SI], lateral and medial prefrontal cortex, pre-
motor cortex, cingulomotor area) (Fig. 5a, b, upper and 
Fig. 4 Modulation of event‑related spectral perturbations by selective attention and heterotopic noxious counter‑stimulation (HNCS). a Mean 
stimulus‑locked event‑related spectral perturbations at electrode Cz. The dashed line indicates the stimulus onset. Oscillation power is presented 
in dB relative to a pre‑stimulus baseline (−400 ms to −100 ms). Positive and negative power changes are represented by red and blue colors, 
respectively. Rectangles represent the following predetermined regions of interest (time x frequency): 4–10 Hz, 50–350 ms; 8–29 Hz, 300–1000 ms; 
30–60 Hz, 50–300 ms; 61–100 Hz, 100–300 ms. The mean power values for the regions of interest (time × frequency) calculated according to the 
top 20% approach (see “Methods” section) and statistical results are illustrated in Table 2 and in “Results” section. X‑axis, time in ms; Y‑axis, frequency 
in Hz. b Power value (mean ± SEM) in dB for high‑gamma oscillations (61–100 Hz, 100–300 ms). The inhibitory effect of HICS and HNCS compared 
with baseline within each session is represented by the * and † symbols. *p < 0.05, †p < 0.01. The inhibitory effect of HNCS compared with HICS 
vs. corresponding changes in the control session is represented by the # symbol. #p > 0.05. X‑axis, conditions and sessions; Y‑axis, power values in 
dB. SEM: standard error of the mean; IBS: irritable bowel syndrome; HICS: heterotopic innocuous counter‑stimulation; HNCS: heterotopic noxious 
counter‑stimulation
(See figure on next page.)
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Fig. 5 Modulation of pain‑related high‑gamma oscillation sources by selective attention and heterotopic noxious counter‑stimulation (HNCS). 
Source estimation of high‑gamma oscillations (at 86 Hz, 158 ms post‑stimulation) represented as t values, based on a voxelwise two‑tailed paired 
t test on time–frequency source space (a patients with IBS; b control group). Time courses of high‑gamma oscillations during HNCS and HICS 
blocks were compared to those during baseline block. Positive and negative relationships are depicted by warm and cool colors, respectively. 
Whole‑brain t‑maps were thresholded at p < 0.05, false discovery rate corrected for the whole brain. Statistical results and MNI coordinates of 
strongest relationships (peak locations) are provided in the “Results” section. Hz: hertz; ms: milliseconds; SI: primary somatosensory cortex; ACC: 
anterior cingulate cortex; DLPFC: dorsolateral prefrontal cortex; IBS: irritable bowel syndrome; HICS: heterotopic innocuous counter‑stimulation; 
HNCS: heterotopic noxious counter‑stimulation
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middle rows, right and left panels). Voxelwise two-tailed 
paired t tests on time–frequency source space were 
then applied: attention to shock pain session, HNCS 
vs. baseline (effect of HNCS); and attention to counter-
stimulation session, HICS vs. baseline (effect of selective 
attention). In patients with IBS, neither HNCS nor selec-
tive attention caused significant changes in cortical foci 
of high-gamma power (Fig. 5a, bottom row, right and left 
panels). In the control group, selective attention resulted 
in statistically significant foci of high-gamma power 
decreases compared with baseline. The foci were located 
in the left lateral prefrontal cortex (including left DLPFC, 
MNI: −46, 38, 8), left medial prefrontal cortex (MNI: −2, 
45, 36), and left anterior cingulate cortex (ACC) (MNI: 
−1, 27, 19) (Fig.  5b, right panels). These effects were 
observed from 154 to 162  ms post-stimulation, mostly 
at 70–90 Hz, peaking at 158 ms and 84 Hz (Fig. 5b, bot-
tom row, right panels). Similarly, HNCS significantly 
decreased high-gamma power compared with baseline. 
The foci were located in the left lateral prefrontal cor-
tex (including left DLPFC, MNI: −46, 38, 8), left premo-
tor regions (−3, 7, 71), bilateral medial prefrontal cortex 
(left, −2, 45, 36 and right, 1, 43, 40), bilateral ACC (left, 
−1, 27, 19 and right, 0, 32, 23), and left foot region of 
primary somatosensory cortex (SI, −6, −42, 79) (Fig. 5b, 
bottom row, left panels).
Modulation of pain perception
Shock pain ratings were compared between groups and 
across experimental sessions and blocks by a mixed 
ANOVA (see Table 2). Pain ratings were not significantly 
different between groups across sessions and blocks 
(interaction:  F6,96 = 0.8, p = 0.6, η2p = 0.05). However, pain 
ratings were significantly different between sessions 
across blocks (interaction:  F6,96 = 3.2, p < 0.006, = 0.17; 
see Table 2 and Fig. 6). This interaction was decomposed 
using planned contrasts to test a priori hypotheses for 
Fig. 6 Modulation of pain perception and NFR amplitude by selective attention and heterotopic noxious counter‑stimulation (HNCS). a Pain 
ratings (mean ± SEM) of the electrical stimulation for each block, session, and group (patients with IBS, left column; control group, right column). 
For mean values and statistical tests, see Table 2 and “Results” section. The inhibitory effect of HICS and HNCS compared with baseline within each 
session is represented by the * and † symbols. *p < 0.05, †p < 0.01. The inhibitory effects of HNCS compared with HICS vs. the corresponding changes 
in the control session is represented by the # symbol. #p > 0.05. X‑axis, conditions and sessions; Y‑axis, pain ratings of the electrical stimulation. b 
Standardized NFR amplitude (T‑score ± SEM) induced by the electrical stimulation for each block, session, and group (patients with IBS, left column; 
control group, right column). For mean values and statistical results, see Table 2 and the “Results” section). X‑axis, conditions and sessions; Y‑axis, 
standardized amplitude (T‑score). NRS: numerical rating scale; SEM: standard error of the mean; IBS: irritable bowel syndrome; HICS: heterotopic 
innocuous counter‑stimulation; HNCS: heterotopic noxious counter‑stimulation
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simple effects (group by group). Statistical within-session 
comparisons are also presented in Table 2 and Fig. 6.
In the control session, pain ratings were not signifi-
cantly different in the second, third, or fourth blocks 
compared with the baseline block for either patients 
with IBS (all p > 0.1) or c the control group (all p > 0.3), 
except for a slight increase of pain ratings in the second 
block compared with baseline block in patients with IBS 
(p < 0.03).
In the attention to shock pain session, HICS did not 
significantly modulate pain ratings in comparison to 
baseline in the control group (p = 0.4), but patients 
with IBS showed increased pain perception (p = 0.05). 
In contrast, HNCS significantly decreased pain ratings 
compared with HICS in comparison to the correspond-
ing changes in the control session in the control group 
(p < 0.05) but not in patients with IBS (p > 0.5), indicating 
that HNCS produced the expected hypoalgesic effect in 
the control group after accounting for temporal non-spe-
cific changes. After HNCS, however, pain ratings did not 
remain significantly decreased in the control group dur-
ing recovery compared with HICS, vs. the corresponding 
changes in the control session (p = 0.5).
In the attention to counter-stimulation session, pain 
ratings were not significantly modulated by HICS com-
pared with baseline, vs. the corresponding changes in 
the attention to shock pain session in either patients 
with IBS (p = 0.2) or the control group (p = 0.1), indicat-
ing that selective attention did not significantly decrease 
pain. Moreover, pain inhibition by HNCS compared with 
HICS was not significantly different, vs. the correspond-
ing changes in the attention to shock pain session either 
in patients with IBS (p > 0.9) or the control group (p > 0.1), 
suggesting that HNCS and selective attention did not 
produce significant additive hypoalgesia, consistent with 
the lack of pain inhibition by selective attention. Addi-
tionally, the ability to decrease pain by selective attention 
may contribute to pain inhibition by HNCS or its altera-
tion in IBS. Accordingly, pain inhibition amplitude by 
HNCS was significantly associated with pain inhibition 
amplitude by selective attention (r = 0.60; p = 0.0008), 
consistent with the same associations observed for the 
N100 and P260.
Nociceptive flexion reflex
NFR amplitude was not significantly different between 
groups across sessions and blocks (interaction:  F6,96 = 0.2, 
p = 0.9, η2p = 0.01; see Table  2). Also, it was not signifi-
cantly different between sessions across blocks (interac-
tion:  F6,96 = 0.6, p = 0.7, η2p = 0.04; see Table 2 and Fig. 6). 
These results indicate that HNCS and selective attention 
did not significantly modulate the NFR in the present 
experimental conditions.
Contribution of pain hypervigilance to altered inhibition 
of pain‑related brain activity
To examine whether group differences in pain vigilance 
may contribute to decreased inhibition of pain-related 
brain activity by HNCS and selective attention, covari-
ance analyses were conducted.
The effects of HNCS and selective attention on the 
N100 and P260 reported above were no longer significant 
after controlling for group differences in pain vigilance 
(interaction:  F6,84 = 2.0, p = 0.07, η2p = 0.13 and  F6,84 = 1.3, 
p = 0.3, η2p = 0.08, respectively), but remained significant 





The present results are consistent with and extend those 
from previous reports indicating that patients with IBS 
show altered pain inhibition processes. In addition to 
altered inhibition of pain and pain-related brain activ-
ity by HNCS, patients with IBS showed altered inhibi-
tion of pain-related brain activity by selective attention. 
Moreover, high-gamma oscillations in ACC and left 
DLPFC were decreased by HNCS and selective attention 
in the control group. The same sources were observed in 
patients with IBS, but their activity was not significantly 
affected by HNCS and selective attention. In addition, 
patients with IBS showed increased pain vigilance, which 
contributed to some of the above-mentioned alterations. 
Altogether, these results indicate that decreased pain 
inhibition by HNCS in patients with IBS reflects interac-
tions between several brain processes related to pain and 
attention and cannot be attributed solely to an alteration 
of the nociceptive system.
Altered pain processing in patients with irritable bowel 
syndrome
In patients with IBS, pain-related brain activity (N100, 
P260, and high-gamma oscillations) and pain percep-
tion were not significantly decreased by HNCS. These 
results are in line with previous studies in which somatic 
pain inhibition by counter-stimulation was decreased or 
abolished in patients with IBS [5–10, 55, 56]. In contrast, 
in the control group, HNCS significantly decreased the 
N100 and P260 compared with HICS and this effect was 
significantly greater vs. the corresponding changes in the 
control session. These results are consistent with previ-
ous electrophysiological studies [38, 57–61] and indi-
cate that HNCS inhibits pain-related brain activity after 
accounting for temporal non-specific changes. Indeed, a 
strength of the present experimental design is that tem-
poral non-specific effects are measured and controlled 
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for during a control session. This excludes confounding 
habituation effects from pain inhibition produced by 
HNCS.
Another strength of the present experimental design 
is the manipulation of selective attention during the 
application of counter-stimulation (innocuous and nox-
ious), which allows two things. First, inhibition of pain 
and pain-related brain activity by selective attention 
can be measured. Second, the contribution of attention 
decreased pain inhibition during HNCS can be assessed. 
Results indicate that patients with IBS show no inhibition 
of pain-related brain activity by selective attention (dis-
traction). In addition, they show a lack of inhibition (pain 
and pain-related brain activity) by HNCS when attention 
is focused either on shock pain or on counter-stimula-
tion. The significant associations between inhibition of 
pain, N100, and P260 by HNCS and inhibition of pain, 
N100, and P260 by selective attention support the idea 
that attentional processes contribute to the inhibition 
deficit observed in patients with IBS. Consistent with the 
lack of inhibition by selective attention, patients with IBS 
reported increased pain vigilance compared with con-
trols. This may indicate that attention is not redirected 
from one source of pain to another, but rather divided 
and maintained on both sources at the same time. Con-
sistent with the idea that pain hypervigilance may con-
tribute to the lack of inhibition by HNCS and selective 
attention, the N100 and P260 inhibition by either inter-
vention was not significant after controlling for individ-
ual differences in pain vigilance. This suggests that group 
differences may be at least partly explained by processes 
underlying pain vigilance. This is in line with studies sug-
gesting that psychological symptoms may contribute 
to the development of IBS [62–64] and studies showing 
increased psychological symptoms in IBS [6, 65–73]. 
However, the effects of HNCS and selective attention on 
high-gamma power remained significant after control-
ling for individual differences in pain vigilance, which 
suggests that psychological factors cannot explain every 
aspect of altered pain processing in IBS and that these 
alterations may develop, at least in part, independently 
from psychological symptoms.
In addition to event-related potentials (N100 and 
P260), painful stimuli also elicit ERSPs. With phasic 
painful stimuli, increased oscillations at low frequen-
cies (1–10  Hz), suppression of alpha and beta oscil-
lations (8–29  Hz), and increased gamma oscillations 
(30–100  Hz) occur between 150 and 350  ms post-stim-
ulus. These responses have been shown to be modulated 
by bottom-up and top–down processes [74], and gamma 
oscillations seem to reflect pain intensity [74]. In the pre-
sent study, these responses were clearly observed, but 
only gamma oscillations were modulated by HNCS and 
selective attention in the control group, while no signifi-
cant change was produced in patients with IBS. In both 
groups, shock pain evoked robust high-gamma oscil-
lations generated by sources located in areas related to 
pain, attention, and cognition. Consistent with the results 
discussed above, shock-evoked high-gamma oscillations 
were attenuated in the control group only, in the left lat-
eral prefrontal cortex (including left DLPFC), left premo-
tor regions, medial prefrontal cortex, ACC, and left foot 
region of primary somatosensory cortex. Inhibition of 
shock pain responses in these structures during sustained 
pain further supports their contribution to counter-stim-
ulation analgesia, in line with previous studies [75–82]. In 
addition, the DLPFC and the ACC are involved in atten-
tion and top–down regulation [83–86]. Their modula-
tion during HNCS and distraction may, therefore, reflect 
changes in these functions to regulate pain in the control 
group, while this mechanism is altered in patients with 
IBS.
Cognitive inhibition in patients with irritable bowel 
syndrome
In the present study, we assessed whether cognitive inhi-
bition was decreased in patients with IBS and whether 
this may contribute to altered pain inhibition processes. 
Reaction times in the naming condition of the Stroop test 
were not significantly different between groups, indicat-
ing that groups were responding equally fast. Although 
the effects did not reach statistical significance, patients 
with IBS showed marginally longer reaction times 
(p = 0.054) during the switching condition. To confirm 
whether cognitive inhibition is decreased in patient 
with IBS, future studies with larger samples are needed 
to replicate these findings. Decreased cognitive inhibi-
tion in patients with IBS would be consistent with several 
studies showing that chronic pain is generally associated 
with impaired response inhibition [87–93]. Previous 
studies have also reported decreased cognitive flexibility 
and impaired visuospatial memory in patents with IBS 
compared with a control group [19, 94]. In patients with 
IBS, lower cognitive performance may affect how pain 
symptoms are processed and perceived and may con-
tribute to altered pain inhibition and further increases in 
chronic pain symptoms. It could be expected that cogni-
tive inhibition may be specifically altered when stimuli 
or information to be inhibited is related to pain. Indeed, 
enhanced attentional capture by pain due to attentional 
bias towards pain-related information has been reported 
in patients with chronic pain [23, 24]. The present results 
indicate that even when stimuli and sensory information 
is unrelated to pain (e.g., words and colors), cognitive 
inhibition tend to be altered in patients with IBS, suggest-
ing that the deficit may apply to any stimulus modality.
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Limitations
The foremost limitation of this study is the sample size, 
which is limited to nine participants per group. There-
fore, although the main results are consistent with 
our hypotheses and with previous findings, the lack of 
group difference for some measures should be inter-
preted with caution and deserves further investiga-
tions. For example, the lack of NFR inhibition by HNCS 
in the control group may be due to a lack of power and 
is not consistent with our previous study that included 
31 participants [27]. However, the NFR results are con-
sistent with some of our previous studies, in which NFR 
was not significantly inhibited by HNCS in healthy vol-
unteers [28, 81]. The discrepancies between studies do 
not seem to rely exclusively on sample size, but also on 
inter-individual differences and variability. Lastly, it 
should be noted that we selected female participants 
only to limit the potential confound of sex differences 
and variability. This limits the generalizability of the 
results.
Conclusion
The present results indicate that brain mechanisms 
involved in pain inhibition by HNCS and selective 
attention are altered in patients with IBS. In addition, 
patients with IBS showed increased pain vigilance, 
which contributed to the above-mentioned alterations. 
Altogether, these results indicate that decreased pain 
inhibition by HNCS in patients with IBS reflects inter-
actions between several brain processes related to pain 
and attention and cannot be attributed solely to altera-
tions of the nociceptive system.
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